EMERALD in the making? A promising blood-based microRNA panel to detect oesophageal adenocarcinoma and Barrett's oesophagus.
作者信息
Iyer Prasad G
机构信息
Gastroenterology and Hepatology, Mayo Clinic, Scottsdale, Arizona, USA
出版信息
Gut. 2025 Jan 28. doi: 10.1136/gutjnl-2025-334795.
Abstract
摘要
相似文献
1
EMERALD in the making? A promising blood-based microRNA panel to detect oesophageal adenocarcinoma and Barrett's oesophagus.正在形成的“翡翠计划”？一种有前景的基于血液的微小RNA检测组合用于检测食管腺癌和巴雷特食管。
Gut. 2025 Jan 28. doi: 10.1136/gutjnl-2025-334795.
2
Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.巴雷特食管的监测：通过系统评价、专家研讨会和经济模型探索不确定性
Health Technol Assess. 2006 Mar;10(8):1-142, iii-iv. doi: 10.3310/hta10080.
3
Evaluation of fatty acid synthase expression in oesophageal mucosa of patients with oesophagitis, Barrett's oesophagus and adenocarcinoma.食管炎、巴雷特食管和腺癌患者食管黏膜中脂肪酸合酶表达的评估。
J Cancer Res Clin Oncol. 2009 Nov;135(11):1533-41. doi: 10.1007/s00432-009-0600-x. Epub 2009 May 27.
4
Systematic review with meta-analysis: risk factors for Barrett's oesophagus in individuals with gastro-oesophageal reflux symptoms.系统评价与荟萃分析：胃食管反流症状个体发生巴雷特食管的危险因素。
Aliment Pharmacol Ther. 2021 May;53(9):968-976. doi: 10.1111/apt.16321. Epub 2021 Mar 11.
5
Treatment for Barrett's oesophagus.巴雷特食管的治疗
Cochrane Database Syst Rev. 2010 Jan 20;2010(1):CD004060. doi: 10.1002/14651858.CD004060.pub2.
6
A systematic review of photodynamic therapy in the treatment of pre-cancerous skin conditions, Barrett's oesophagus and cancers of the biliary tract, brain, head and neck, lung, oesophagus and skin.光动力疗法治疗癌前皮肤状况、巴雷特食管和胆道、脑、头颈部、肺、食管和皮肤癌症的系统评价。
Health Technol Assess. 2010 Jul;14(37):1-288. doi: 10.3310/hta14370.
7
Systematic review with meta-analysis: prevalent vs. incident oesophageal adenocarcinoma and high-grade dysplasia in Barrett's oesophagus.系统评价与荟萃分析：巴雷特食管中食管腺癌和高级别异型增生的患病率与发病率对比
Aliment Pharmacol Ther. 2016 Oct;44(8):775-84. doi: 10.1111/apt.13783. Epub 2016 Aug 26.
8
Biomarker risk stratification with capsule sponge in the surveillance of Barrett's oesophagus: prospective evaluation of UK real-world implementation.在巴雷特食管监测中使用胶囊海绵进行生物标志物风险分层：英国实际应用的前瞻性评估。
Lancet. 2025 Jul 19;406(10500):271-282. doi: 10.1016/S0140-6736(25)01021-9. Epub 2025 Jun 23.
9
Infectious agents and progression from Barrett's oesophagus to oesophageal adenocarcinoma: a nested case-control study.感染因子与巴雷特食管向食管腺癌的进展：一项巢式病例对照研究。
Br J Cancer. 2025 Apr 8. doi: 10.1038/s41416-025-03003-7.
10
Length of Barrett's oesophagus and cancer risk: implications from a large sample of patients with early oesophageal adenocarcinoma.巴雷特食管长度与癌症风险：来自一大群早期食管腺癌患者的启示。
Gut. 2016 Feb;65(2):196-201. doi: 10.1136/gutjnl-2015-309220. Epub 2015 Jun 25.
本文引用的文献
1
Liquid biopsy to identify Barrett's oesophagus, dysplasia and oesophageal adenocarcinoma: the multicentre study.液体活检用于识别巴雷特食管、发育异常和食管腺癌：多中心研究
Gut. 2025 Jan 17;74(2):169-181. doi: 10.1136/gutjnl-2024-333364.
2
Non-invasive diagnosis of esophageal cancer by a simplified circulating cell-free DNA methylation assay targeting OTOP2 and KCNA3: a double-blinded, multicenter, prospective study.通过针对 OTOP2 和 KCNA3 的简化循环无细胞 DNA 甲基化分析对食管癌进行无创诊断：一项双盲、多中心、前瞻性研究。
J Hematol Oncol. 2024 Jun 18;17(1):47. doi: 10.1186/s13045-024-01565-2.
3
The Public's Intended Uptake of Hypothetical Esophageal Adenocarcinoma Screening Scenarios: A Nationwide Survey.公众对假设的食管腺癌筛查方案的预期接受情况：一项全国性调查。
Am J Gastroenterol. 2024 Sep 1;119(9):1802-1812. doi: 10.14309/ajg.0000000000002812. Epub 2024 Apr 15.
4
Algorithm Training and Testing for a Nonendoscopic Barrett's Esophagus Detection Test in Prospective Multicenter Cohorts.前瞻性多中心队列中用于非内镜 Barrett 食管检测试验的算法训练和测试。
Clin Gastroenterol Hepatol. 2024 Aug;22(8):1596-1604.e4. doi: 10.1016/j.cgh.2024.03.003. Epub 2024 Mar 19.
5
Development of Electronic Health Record-Based Machine Learning Models to Predict Barrett's Esophagus and Esophageal Adenocarcinoma Risk.基于电子健康记录的机器学习模型在预测巴雷特食管和食管腺癌风险中的开发。
Clin Transl Gastroenterol. 2023 Oct 1;14(10):e00637. doi: 10.14309/ctg.0000000000000637.
6
Low Prevalence of Endoscopic Screening for Barrett's Esophagus in a Screening-Eligible Primary Care Population.筛查合格的初级保健人群中 Barrett 食管内镜筛查的患病率较低。
Am J Gastroenterol. 2022 Nov 1;117(11):1764-1771. doi: 10.14309/ajg.0000000000001935. Epub 2022 Aug 12.
7
Diagnosis and Management of Barrett's Esophagus: An Updated ACG Guideline. Barrett 食管的诊断和管理：ACG 指南更新。
Am J Gastroenterol. 2022 Apr 1;117(4):559-587. doi: 10.14309/ajg.0000000000001680.
8
Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial.Cytosponge-三叶因子 3 与常规护理在初级保健环境中识别 Barrett 食管：一项多中心、实用、随机对照试验。
Lancet. 2020 Aug 1;396(10247):333-344. doi: 10.1016/S0140-6736(20)31099-0.
9
Discovery, Validation, and Application of Novel Methylated DNA Markers for Detection of Esophageal Cancer in Plasma.发现、验证和应用新型甲基化 DNA 标志物用于检测血浆中的食管癌。
Clin Cancer Res. 2019 Dec 15;25(24):7396-7404. doi: 10.1158/1078-0432.CCR-19-0740. Epub 2019 Sep 16.
10
Feasibility of mcroRNAs as biomarkers for Barrett's Esophagus progression: a pilot cross-sectional, phase 2 biomarker study.微小 RNA 作为巴雷特食管进展生物标志物的可行性：一项初步的、基于 2 期生物标志物的横断面研究。
Am J Gastroenterol. 2011 Jun;106(6):1055-63. doi: 10.1038/ajg.2011.37. Epub 2011 Mar 15.
Zotero 插件